Chronic (one-month) treatment with low-dose aspirin was shown to reduce plasma LPA levels in patients with cerebrovascular disease [72], but acute ingestion of a higher dose of aspirin had no effect on plasma LPA levels or ATX activity in healthy volunteers [73]. The gene discussed is ENPP2; the disease is cerebrovascular disorder.